InNeuroCo
InNeuroCo was a private Pembroke Pines, Florida medical device company founded in 2014 that specialized in neurovascular catheter design and production, and was acquired by Integer Holdings Corporation for $44.5 million in October 2023.
- Company typePrivate
- Founded2014
- HeadquartersPembroke Pines, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
InNeuroCo firmographics
Firmographics- Name
- InNeuroCo
- Legal name
- InNeuroCo, Inc.
- Website
- https://inneuroco.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- InNeuroCo was a private Pembroke Pines, Florida medical device company founded in 2014 that specialized in neurovascular catheter design and production, and was acquired by Integer Holdings Corporation for $44.5 million in October 2023.
- Ownership category
- akta.pro rank
InNeuroCo industry classification
Industry- Product category
- Neurovascular Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)
Keywords
Where InNeuroCo is headquartered
LocationHeadquarters
- HQ city
- Pembroke Pines
- HQ country
- United States
- HQ region
- North America
Markets served
InNeuroCo business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
InNeuroCo product offering
Product offeringCore offering
InNeuroCo was a neurovascular medical device company that designed and produced catheters used in challenging neurointerventional procedures. The company focused on catheter engineering and manufacturing capabilities for accessing and treating complex neurovascular anatomy. Its assets were acquired by Integer Holdings Corporation in October 2023 for $44.5 million, integrating those catheter design and production capabilities into Integer's medical device portfolio.
Differentiator
Problem solved
Functional benefit
Products and services
- Neurovascular Catheters Catheters engineered for use in challenging neurointerventional procedures, designed to navigate complex neurovascular anatomy; intended for hospitals and clinical centers performing neurointerventional surgery.
Companies that use InNeuroCo
Customer profileIdeal customer profiles1 record
InNeuroCo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
InNeuroCo partnerships and signals
Strategic signalScale indicators1 record
InNeuroCo competitors and assessment
Company assessmentBroad incumbents
- Medtronic Neurovascular: Medtronic's neurovascular business (historically built on the Covidien/ev3 pipeline of access, aspiration, and delivery catheters for stroke) competes with InNeuroCo across the same neurovascular catheter procedures and represents a major incumbent acquirer/competitor in the space.
- Stryker (Neurovascular): Stryker's neurovascular division (built largely through acquisitions of Concentric and Surpass) offers a broad portfolio of neurovascular access and delivery catheters; as a large diversified medtech incumbent it overlapped with InNeuroCo's specialty catheter focus, and was a natural strategic benchmark.
- Cerenovus (Johnson & Johnson): Cerenovus is J&J's neurovascular arm offering a broad suite of catheters, coils, and access products for stroke and aneurysm treatment; it is a meaningful incumbent with overlapping neurovascular catheter capabilities to InNeuroCo.
Emerging players
- MIVI Neuroscience: MIVI Neuroscience develops neurovascular access and aspiration catheters for stroke treatment; as a smaller, emergent neurovascular catheter developer it is comparable to InNeuroCo's profile in stage and category.
Direct peers
- Wallaby Medical: Wallaby Medical is a neurovascular-focused company offering catheter-based and stent-retriever products for stroke intervention; its product scope and clinical focus closely mirror InNeuroCo's neurovascular catheter positioning.
- Phenox: Phenox develops and markets neurovascular catheters, stents, and coil-assisted devices used in stroke and aneurysm procedures; as a focused neurovascular specialist, it is a direct comparable to InNeuroCo's catheter design activity.
- Acandis: Acandis is a German specialist in neurovascular devices including access and delivery catheters for treating ischemic and hemorrhagic stroke; it is a direct small-cap peer in the same niche InNeuroCo targeted.
- Penumbra: Penumbra is a leading specialist in neurovascular catheters and aspiration/embolization systems for stroke treatment; it directly competes with InNeuroCo in the neurovascular catheter category and served as a benchmark specialty player in the same market.
Others
- Integer Holdings Corporation: Integer Holdings is the strategic acquirer of InNeuroCo's assets and a contract medical device manufacturer with growing neurovascular capability; it is best characterized as an enabling/strategic ecosystem participant relative to InNeuroCo's specific catheter IP.
Regional players
- MicroPort NeuroTech: MicroPort's neurovascular business offers catheter-based products for cerebrovascular intervention in Asia and other markets; it is a regional neurovascular catheter peer with overlapping therapeutic focus to InNeuroCo.
Market position
Customer concentration
InNeuroCo social profiles
Digital presenceInNeuroCo financial estimates
Financial estimateRevenue estimate
Valuation estimate
InNeuroCo leadership team
Management profileNumber of profiles
Profiles2 records
InNeuroCo funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InNeuroCo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InNeuroCo
What does InNeuroCo do?
InNeuroCo was a neurovascular medical device company that designed and produced catheters used in challenging neurointerventional procedures. The company focused on catheter engineering and manufacturing capabilities for accessing and treating complex neurovascular anatomy. Its assets were acquired by Integer Holdings Corporation in October 2023 for $44.5 million, integrating those catheter design and production capabilities into Integer's medical device portfolio.
Is InNeuroCo a public or private company?
InNeuroCo is a private company. It is classified as corporate owned and is currently acquired.
When was InNeuroCo founded?
InNeuroCo was founded in 2014. It employs 11 to 50 people.
Where is InNeuroCo based?
InNeuroCo is headquartered in Pembroke Pines, United States, in the North America region.
Who are InNeuroCo's main competitors?
Broad incumbents on record are Medtronic Neurovascular, Stryker (Neurovascular) and Cerenovus (Johnson & Johnson). MIVI Neuroscience is listed as an emerging player. Direct peers are Wallaby Medical, Phenox, Acandis and Penumbra. Integer Holdings Corporation is listed as an others. MicroPort NeuroTech is listed as a regional player.
Does InNeuroCo have an API?
No public API is recorded for InNeuroCo.
What industry is InNeuroCo in?
InNeuroCo's product category is Neurovascular Medical Devices. Its primary akta.pro industry code is HLAHAKAE, Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories). Its NAICS code is 339113 and its SIC code is 3841.